Avecho Biotechnology Ltd has released a press release.
June 2021 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Avecho to Present New CBD Data at GCI Virtual Summit
- Chairs Address and CEO Presentation
- AB Vista to explore new TPM applications for Animal Health
- TGA meeting for CBD soft-gel targeting insomnia
- Avecho completes pharmaceutical CBD soft-gel product
Later from Avecho Biotechnology
- Phase I clinical trial testing CBD product-enrolment begins
- Dosing begins in Phase I PK trial testing CBD soft-gel
- Topical CBD pain study with Lambert Initiative approved
- September 2021 Quarterly Activities Report & Appendix 4C
- Positive results from Avechos Phase I trial of CBD soft-gel
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology